{"version":"1.0","provider_name":"Kelemen Kinga \u00fcgyv\u00e9di iroda","provider_url":"https:\/\/kpli.hu\/en\/","author_name":"kpli","author_url":"https:\/\/kpli.hu\/en\/author\/kpli\/","title":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"2u9s5myVNn\"><a href=\"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/\">Decision of OGY\u00c9I regarding pharmaceutical commercial practice<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/embed\/#?secret=2u9s5myVNn\" width=\"600\" height=\"338\" title=\"&#8220;Decision of OGY\u00c9I regarding pharmaceutical commercial practice&#8221; &#8212; Kelemen Kinga \u00fcgyv\u00e9di iroda\" data-secret=\"2u9s5myVNn\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/kpli.hu\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","thumbnail_width":600,"thumbnail_height":600,"description":"In February 2021 OGY\u00c9I published a new decision in which it imposed a penalty of HUF 34 million on a pharmaceutical company. Infringements of the Company The Company provided health care professionals with information materials containing inaccurate claims not proven by literature and being in contradiction with the statements made in the summary of product [&hellip;]"}